Amniotic Membrane Transplantation for Painful Bullous Keratopathy

Purpose To establish the effectiveness of amniotic membrane transplantation (AMT) in relieving pain and discomfort in patients with painful bullous keratopathy and also its role in improving vision in eyes with visual potential. Methods Seven eyes of seven consecutive patients with painful corneal conditions were included in a retrospective interventional noncomparative case series performed at Maidstone General hospital, Maidstone, UK. Amniotic membrane transplantation was performed in seven eyes. Pain relief, epithelial healing, and visual changes were evaluated. Pain relief and freedom from discomfort were considered for the success of the surgery. Results The mean follow-up was 26.57 weeks (range 11 to 53 weeks). Pain relief was achieved in all seven (100%) eyes. Associated symptoms including foreign body sensation, photophobia, and tearing subsided significantly in all patients starting soon after the first postoperative day. Vision improved in 5 (71.42%) patients. Conclusions AMT is an effective alternative for the management of patients with painful bullous keratopathy. Besides pain relief and reduction of ocular inflammation it remains unclear whether this procedure can also be used to improve vision in eyes with visual potential. (Eur J Ophthalmol 2007; 17: 7–10)

[1]  Wei Li,et al.  How does amniotic membrane work? , 2004, The ocular surface.

[2]  S. Tseng,et al.  Amniotic membrane transplantation for bullous keratopathy in eyes with poor visual potential , 2003, Journal of cataract and refractive surgery.

[3]  L. F. Mejía,et al.  Symptomatic Management of Postoperative Bullous Keratopathy With Nonpreserved Human Amniotic Membrane , 2002, Cornea.

[4]  H. Taylor,et al.  A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy , 2001, The British journal of ophthalmology.

[5]  S. Tseng,et al.  Amniotic membrane transplantation for symptomatic bullous keratopathy. , 1999, Archives of ophthalmology.

[6]  S. Tseng,et al.  Suppression of transforming growth factor‐beta isoforms, TGF‐β receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix , 1999 .

[7]  A. Kanellopoulos,et al.  Conjunctival flaps. , 1998, Ophthalmology.

[8]  E. Cohen,et al.  Ulcerative keratitis in bullous keratopathy. , 1997, Ophthalmology.

[9]  M. Guertin,et al.  Anterior stromal punctures for bullous keratopathy. , 1996, Archives of ophthalmology.

[10]  A. Nesburn,et al.  Extracellular matrix alterations in human corneas with bullous keratopathy. , 1996, Investigative ophthalmology & visual science.

[11]  S. Tseng,et al.  Transplantation of Preserved Human Amniotic Membrane for Surface Reconstruction in Severely Damaged Rabbit Corneas , 1995, Cornea.

[12]  A. Gasset,et al.  Bandage lenses in the treatment of bullous keratopathy. , 1971, American journal of ophthalmology-glaucoma.

[13]  A. D. Rötth PLASTIC REPAIR OF CONJUNCTIVAL DEFECTS WITH FETAL MEMBRANES , 1940 .